QINGDAO, China, Aug. 24, 2024 /PRNewswire/ — The launch of the highly anticipated Black Myth: Wukong marked a step change in the gaming industry. China’s landmark AAA game, paired with Hisense’s exceptional display capabilities, offers a visually stunning journey through the rich tapestry of Chinese storytelling. Join a global community of gamers and discover the timeless […]
Category Archives: Pr Newswire
BEIJING, Aug. 23, 2024 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that its R&D team delved into the application potential of blockchain in the field of identity management. The decentralized nature of blockchain as an open distributed ledger offers the […]
Total revenue of RMB 254.2 million for 2024 H1; achieving first-time profitability with cash reserve at RMB 814 million as of June 30, 2024. NDA approval of sugemalimab (PD-L1) for Stage IV NSCLC in EU, marking the first successful international approval of a China domestic anti-PD-L1 mAb. Partnered with Ewopharma for sugemalimab commercialization in Central […]
23
Aug
Aug
Hangzhou, China, Aug. 23, 2024 (GLOBE NEWSWIRE) — WORK Medical Technology Group LTD (the “Company”), a supplier of medical devices in China, today announced the pricing of the initial public offering (the “Offering”) of its 2,000,000 ordinary shares at a public offering price of US$4.00 per ordinary share. The ordinary shares have been approved for […]
Pr Newswire
European Commission approves BALVERSA®▼ (erdafitinib) for adult patients with unresectable or metastatic urothelial carcinoma
23
Aug
Aug
First pan FGFR kinase inhibitor to be approved in the European Economic Area, for adults with unresectable or metastatic urothelial carcinoma and susceptible FGFR3 alterations Approval based on THOR results, showing 36 percent reduction in risk of death with erdafitinib versus chemotherapy1 BEERSE, BELGIUM, Aug. 23, 2024 (GLOBE NEWSWIRE) — Janssen-Cilag International NV, a Johnson […]
23
Aug
Aug
WALTHAM, Mass., Aug. 23, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 4-6 in Boston. Olivier Loeillot, President and Chief Executive Officer will participate in an analyst-led discussion on Friday, September […]
23
Aug
Aug
LONDON and NEW YORK, Aug. 23, 2024 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease (DED), a multi-billion-dollar market, and anterior ocular segment diseases including neuropathic corneal pain (NCP), an ocular condition associated with pain but without an FDA […]
Pr Newswire
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of Shareholders
23
Aug
Aug
CALGARY, Alberta, Aug. 23, 2024 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the management information circular (the “Circular”) for the annual and special meeting (the […]
SHANGHAI, Aug. 23, 2024 /PRNewswire/ — GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced China’s National Medical Products Administration has approved Dupert®（fulzerasib, GFH925/IBI351）for the treatment of patients with advanced non-small cell lung cancer (NSCLC) harboring KRAS G12C mutation who have received at least one systemic therapy. Fulzerasib was the […]
HO CHI MINH CITY, Vietnam, Aug. 23, 2024 /PRNewswire/ — The International Travel Expo Ho Chi Minh City (ITE HCMC 2024) is set to become one of Asia’s most influential travel expos, driven by participation from leading global organizations and businesses, increased attention from prestigious international media, and continuous enhancements to its International Hosted Buyer […]